In a new study published in the Journal of Experimental Medicine, scientists at the University of Notre Dame have discovered that the pathogen Mycobacterium tuberculosis (MTB) releases RNA into infected cells. This RNA stimulates the production of a compound known as interferon beta that appears to support the growth of the pathogen. As part of
Scientists at The Wistar Institute and collaborators have successfully engineered novel DNA-encoded monoclonal antibodies (DMAbs) targeting Zaire Ebolavirus that were effective in preclinical models. Study results, published online in Cell Reports, showed that DMAbs were expressed over a wide window of time and offered complete and long-term protection against lethal virus challenges. DMAbs may also
Michael Phelps. Photo: Talkspace (HealthDay)—Swimmer extraordinaire Michael Phelps has won 28 Olympic medals—23 of them gold. Yet, despite all those medals and the accolades that came with them, Phelps has struggled with depression and anxiety. In 2014, it got so bad that he locked himself in his bedroom and stayed there for days. “During those
WEDNESDAY, Oct. 17, 2018 — A precision map of a part of the brain of the lowly mouse could be a potent new research tool against Alzheimer’s, researchers say. The highly detailed look at the mouse hippocampus should provide new insight into a range of brain diseases in humans, according to the research team from
In a new study researchers have developed a two-pronged approach for targeting Ebola virus infection using linked nucleic acid (LNA) antisense oligonucleotides (ASOs)designed to interfere both genes essential for translation of Ebola virus genes and to block production of an intracellular human protein needed for the virus to enter cells. The results of using LNA
A tumor-specific vaccine combined with an immune checkpoint inhibitor shrank tumors in one third of patients with incurable cancer related to the human papilloma virus (HPV) in a phase II clinical trial led by investigators at The University of Texas MD Anderson Cancer Center and reported in JAMA Oncology. “That encouraging response rate is about
An experimental cancer vaccine that boosts the immune system’s ability to fight cancers could work in tandem with other cancer therapies to fight aggressive tumors, scientists reported recently in the Proceedings of the National Academy of Sciences. The researchers demonstrated that adding a molecule called Diprovocim to a vaccine can draw cancer-fighting cells to tumor
Routine testing for prostate cancer is not recommended for most men because the benefit is small and uncertain and there are clear harms, say a panel of international experts in The BMJ today. But they acknowledge that some men, such as those with a family history of prostate cancer, may be more likely to consider
An international research team, led by Professor Peter Collignon from The Australian National University (ANU) Medical School, has found we need to take a much broader approach than simply focusing on antibiotic usage, when it comes to fighting the spread of “superbugs”. Superbugs—or strains of bacteria that have adapted after coming into contact with antibiotics—are
MONDAY, Aug. 20, 2018 — A new class of natural-based mosquito repellents appears to be effective, researchers report. Each year, nearly 700 million people worldwide contract mosquito-borne diseases, such as malaria, West Nile, Zika and dengue fever, resulting in more than 1 million deaths. Many mosquito species have become resistant to commonly used pyrethroid-based insecticides,
A devastating form of childhood epilepsy that is resistant to traditional drugs may have met its match in spider venom. Researchers from The University of Queensland and the Florey Institute of Neuroscience and Mental Health discovered that a peptide in spider venom can restore the neural deficiencies that trigger seizures associated with Dravet syndrome. UQ
Dengue and Zika viruses are closely related and carried by mosquitos. In infested subtropical and tropical areas, dengue transmission often precedes Zika virus (ZIKV) infection, suggesting that women who previously acquired dengue immunity may be bitten by ZIKV-carrying mosquitoes during pregnancy. Whether that mother’s prior dengue immunity would protect her unborn baby from devastating brain
Purdue University researchers have identified a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the Food and Drug Administration to treat life-threatening infections while also appearing to be less susceptible to bacterial resistance. The compound, called F6, has been potent against antibiotic-resistant pathogens such as methicillin-resistant
A new anti-cancer drug may be effective against a wider range of cancers than previously thought. Using a mouse model and samples taken from cancer patients, a team from the Technical University of Munich (TUM) has shown that a new class of drugs known as SHP2 inhibitors is also effective against aggressive, hard-to-treat tumors such
Innate fear is an essential emotion for animals to avoid danger in a severe natural environment. Rodents kept in a laboratory also show instinctive fear behavior against the smell of predators such as foxes, cats or snakes despite having never seen them. This innate fear represents an evolutionarily conserved and genetically encoded survival mechanism. However,
Prion diseases are slow degenerative brain diseases that occur in people and various other mammals. No vaccines or treatments are available, and these diseases are almost always fatal. Scientists have found little evidence of a protective immune response to prion infections. Further, microglia—brain cells usually involved in the first level of host defense against infections
Prostate cancer is the commonest form of cancer in the Western world. Between 15 to 20 percent of men are affected by it at some time in their lives and 2.6 percent die from prostate cancer. That equates to 1,000 deaths a year in Austria. Apart from genetic factors, environmental (epigenetic) risk factors also play
Probiotics may be a relatively safe, simple, and low-cost solution for preventing Clostridium difficile infections (CDI) in hospital settings, according to two studies published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America. Both studies show that treating patients who received antibiotics with multi-strain probiotics, cut down
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok